✦ LIBER ✦

Bright ideas are not enough: From innovation to results

Book ID: 102474052
Publisher: John Wiley and Sons
Year: 2004
Weight: 48 KB
Volume: 2004
Category: Article
ISSN: 1087-8149
DOI: 10.1002/ltl.90

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Why breakthrough products alone don't guarantee success in the marketplace.

📜 SIMILAR VOLUMES

Are Islamic finance innovations enough f

Are Islamic finance innovations enough for investors to escape from a financial downturn? Further evidence from portfolio simulations

✍ Arouri, M. E.; Ben Ameur, H.; Jawadi, N.; Jawadi, F.; Louhichi, W. 📂 Article 📅 2013 🏛 Taylor and Francis Group 🌐 English ⚖ 188 KB

The role of the firm's internal and rela

The role of the firm's internal and relational capabilities in clusters: when distance and embeddedness are not enough to explain innovation

✍ Hervas-Oliver, J.-L.; Albors-Garrigos, J. 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 171 KB

Eutrophication and fragmentation are rel

Eutrophication and fragmentation are related to species’ rate of decline but not to species rarity: results from a functional approach

✍ Christine Römermann; Oliver Tackenberg; Anne-Kathrin Jackel; Peter Poschlod 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 476 KB

Author’s reply to the comment on “Chemis

Author’s reply to the comment on “Chemists’ views on measurement results are influenced too much by statistical considerations and not enough by the application of simple metrological principles”

✍ Paul De Bièvre 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 96 KB

Not all head-to-head trials are created

Not all head-to-head trials are created equal: Results from an open-label, short-term study seem inconsistent with previous donepezil literature

✍ Roger Bullock; Luc Truyen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

## Dear Editor In their research letter 'Selective serotonin reuptake inhibitors (SSRIs) and hyponatraemia in the elderly', Wee and Lim (2004) are quite wrong to state in regard to hyponatraemia and SSRIs that 'no studies are available in geriatric populations'. Such a study was published in this

Opposite effects of the CD30 ligand are

Opposite effects of the CD30 ligand are not due to CD30 mutations: Results from cDNA cloning and sequence comparison of the CD30 antigen from different sources

✍ Wolfram Jung; Stefan Krueger; Christoph Renner; Angela Gause; Ugur Sahin; Lorenz 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 716 KB